All Stories

  1. Smad2 linker region phosphorylation is an autonomous cell signalling pathway: Implications for multiple disease pathologies

    Article • Biomedicine & Pharmacotherapy, April 2020, Elsevier

    Danielle Kamato

  2. The Role of Toll-like Receptors in Atherothrombotic Cardiovascular Disease

    Article • ACS Pharmacology & Translational Science, February 2020, American Chemical Society (ACS)

    Danielle Kamato

  3. ROS directly activates transforming growth factor β type 1 receptor signalling in human vascular smooth muscle cells

    Article • Biochimica et Biophysica Acta (BBA) - General Subjects, January 2020, Elsevier

    Danielle Kamato

  4. Lysophosphatidic acid and its receptors: pharmacology and therapeutic potential in atherosclerosis and vascular disease

    Article • Pharmacology & Therapeutics, December 2019, Elsevier

    Danielle Kamato

  5. GPCR transactivation signalling in vascular smooth muscle cells: role of NADPH oxidases and reactive oxygen species

    Article • Vascular Biology, August 2019, Bioscientifica

    Danielle Kamato

  6. Smad linker region phosphorylation is a signalling pathway in its own right and not only a modulator of canonical TGF-β signalling

    Article • Cellular and Molecular Life Sciences, August 2019, Springer Science + Business Media

    Danielle Kamato

  7. Mechanisms of PAR-1 mediated kinase receptor transactivation: Smad linker region phosphorylation

    Article • Journal of Cell Communication and Signaling, July 2019, Springer Science + Business Media

    Danielle Kamato

  8. Treatment of atherosclerotic plaque: perspectives on theranostics

    Article • Journal of Pharmacy and Pharmacology, April 2019, Wiley

    Danielle Kamato

  9. Individual Smad2 linker region phosphorylation sites determine the expression of proteoglycan and glycosaminoglycan synthesizing genes

    Article • Cellular Signalling, January 2019, Elsevier

    Danielle Kamato

  10. Endothelial function and dysfunction: Impact of metformin

    Article • Pharmacology & Therapeutics, December 2018, Elsevier

    Mrs Susan G Gray, Danielle Kamato

  11. Transforming growth factor–β1 mediated CHST11 and CHSY1 mRNA expression is ROS dependent in vascular smooth muscle cells

    Article • Journal of Cell Communication and Signaling, November 2018, Springer Science + Business Media

    Danielle Kamato

  12. Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics

    Article • Pharmacology & Therapeutics, November 2018, Elsevier

    Danielle Kamato

  13. Thrombin promotes PAI-1 expression and migration in keratinocytes via ERK dependent Smad linker region phosphorylation

    Article • Cellular Signalling, July 2018, Elsevier

    Danielle Kamato

  14. Signalling pathways regulating galactosaminoglycan synthesis and structure in vascular smooth muscle: Implications for lipoprotein binding and atherosclerosis

    Article • Pharmacology & Therapeutics, July 2018, Elsevier

    Danielle Kamato

  15. G protein coupled receptors can transduce signals through carboxy terminal and linker region phosphorylation of Smad transcription factors

    Article • Life Sciences, April 2018, Elsevier

    Danielle Kamato

  16. Flavopiridol Inhibits TGF-β-Stimulated Biglycan Synthesis by Blocking Linker Region Phosphorylation and Nuclear Translocation of Smad2

    Article • Journal of Pharmacology and Experimental Therapeutics, February 2018, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Danielle Kamato

  17. Activatable magnetic resonance nanosensor as a potential imaging agent for detecting and discriminating thrombosis

    Article • Nanoscale, January 2018, Royal Society of Chemistry

    Danielle Kamato

  18. RNA sequencing to determine the contribution of kinase receptor transactivation to G protein coupled receptor signalling in vascular smooth muscle cells

    Article • PLoS ONE, July 2017, PLOS

    Danielle Kamato

  19. Animal models for assessing the impact of natural products on the aetiology and metabolic pathophysiology of Type 2 diabetes

    Article • Biomedicine & Pharmacotherapy, May 2017, Elsevier

    Mrs Susan G Gray, Danielle Kamato

  20. Insights into cellular signalling by G protein coupled receptor transactivation of cell surface protein kinase receptors

    Article • Journal of Cell Communication and Signaling, February 2017, Springer Science + Business Media

    Danielle Kamato

  21. Endothelin-1 (ET-1) stimulates carboxy terminal Smad2 phosphorylation in vascular endothelial cells by a mechanism dependent on ET receptors andde novoprotein synthesis

    Article • Journal of Pharmacy and Pharmacology, December 2016, Wiley

    Danielle Kamato

  22. Gaq proteins: molecular pharmacology and therapeutic potential

    Article • Cellular and Molecular Life Sciences, November 2016, Springer Science + Business Media

    Danielle Kamato

  23. The role of specific Smad linker region phosphorylation in TGF-β mediated expression of glycosaminoglycan synthesizing enzymes in vascular smooth muscle

    Article • Cellular Signalling, August 2016, Elsevier

    Danielle Kamato

  24. Evaluation of the potential synergism of imatinib-related poly kinase inhibitors using growth factor stimulated proteoglycan synthesis as a model response

    Article • Journal of Pharmacy and Pharmacology, February 2016, Wiley

    Danielle Kamato

  25. Integrating the GPCR transactivation-dependent and biased signalling paradigms in the context of PAR1 signalling

    Article • British Journal of Pharmacology, February 2016, Wiley

    Danielle Kamato

  26. Multiple Growth Factors, But Not VEGF, Stimulate Glycosaminoglycan Hyperelongation in Retinal Choroidal Endothelial Cells

    Article • International Journal of Biological Sciences, January 2016, Ivyspring International Publisher

    Danielle Kamato

  27. Protease activated receptor-1 mediated dual kinase receptor transactivation stimulates the expression of glycosaminoglycan synthesizing genes

    Article • Cellular Signalling, January 2016, Elsevier

    Danielle Kamato

  28. Structure, Function, Pharmacology, and Therapeutic Potential of the G Protein, Gα/q,11

    Article • Frontiers in Cardiovascular Medicine, March 2015, Frontiers

    Danielle Kamato

  29. Peptidyl-prolyl isomerases: Functionality and potential therapeutic targets in cardiovascular disease

    Article • Clinical and Experimental Pharmacology and Physiology, January 2015, Wiley

    Danielle Kamato

  30. The expansion of GPCR transactivation-dependent signalling to include serine/threonine kinase receptors represents a new cell signalling frontier

    Article • Cellular and Molecular Life Sciences, November 2014, Springer Science + Business Media

    Danielle Kamato

  31. 25Years of endothelin research: the next generation

    Article • Life Sciences, November 2014, Elsevier

    Dr Nicolas Vignon-Zellweger, Danielle Kamato

  32. Transforming growth factor β-mediated site-specific Smad linker region phosphorylation in vascular endothelial cells

    Article • Journal of Pharmacy and Pharmacology, October 2014, Wiley

    Danielle Kamato

  33. Assessing the Role of Gαq/11 in Cellular Responses: An Analysis of Investigative Tools

    Article • Clinical and Experimental Pharmacology, January 2014, OMICS Publishing Group

    Danielle Kamato

  34. Atherogenic, fibrotic and glucose utilising actions of glucokinase activators on vascular endothelium and smooth muscle

    Article • Cardiovascular Diabetology, January 2014, Springer Science + Business Media

    Danielle Kamato

  35. Assessing the Role of Gαq/11 in Cellular Responses: An Analysis of Investigative Tools

    Article • Clinical and Experimental Pharmacology, January 2014, OMICS Publishing Group

    Danielle Kamato

  36. Transforming growth factor-β signalling: Role and consequences of Smad linker region phosphorylation

    Article • Cellular Signalling, October 2013, Elsevier

    Dr Suowen Xu, Danielle Kamato

  37. Suramin inhibits PDGF-stimulated receptor phosphorylation, proteoglycan synthesis and glycosaminoglycan hyperelongation in human vascular smooth muscle cells

    Article • Journal of Pharmacy and Pharmacology, April 2013, Wiley

    Danielle Kamato

  38. (S)-[6]-Gingerol inhibits TGF-β-stimulated biglycan synthesis but not glycosaminoglycan hyperelongation in human vascular smooth muscle cells

    Article • Journal of Pharmacy and Pharmacology, March 2013, Wiley

    Danielle Kamato

  39. Therapeutic implications of endothelin and thrombin G-protein-coupled receptor transactivation of tyrosine and serine/threonine kinase cell surface receptors

    Article • Journal of Pharmacy and Pharmacology, August 2012, Wiley

    Danielle Kamato

  40. Cell biology of Smad2/3 linker region phosphorylation in vascular smooth muscle

    Article • Clinical and Experimental Pharmacology and Physiology, July 2012, Wiley

    Danielle Kamato